Podcasts about Vertex

The Rollup TV is brought to you by:Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Vertex: https://vertexprotocol.com/Subsquid: https://www.sqd.ai/Summer: https://summer.fi/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Introduction02:15 Crypto Week in the USA10:45 Union's Big Announcement25:30 Securitize's Tokenization Journey40:00 Songcoins and Music Innovation55:00 Closing Remarks

Vertex is an open source nostr web of trust provider. Webs of trust are a method of quantifying verifiable reputations for spam mitigation, user discovery, social feeds, better app stores, and more.Pip on Nostr: https://primal.net/p/nprofile1qqs0dqlgwq6l0t20gnstnr8mm9fhu9j9t2fv6wxwl3xtx8dh24l4auswr6u0j Vertex on Nostr: https://primal.net/p/nprofile1qqstq4j6pk2sgaupru6l7ah9nq0dueafq356jllwcy7uzlek9yx7hlsel8nqn Vertex: https://vertexlab.io/ EPISODE: 167BLOCK: 905116PRICE: 847 sats per dollar(00:00:01) CNBC Intro(00:02:00) Happy Bitcoin Friday(00:04:27) Pip and Webs of Trust(00:06:49) Understanding Webs of Trust(00:14:16) App Store Security and Trust(00:18:53) Spam Mitigation(00:28:11) Client Side Solutions and Performance(00:35:33) Trust Models and Censorship Risks(00:45:02) Use Cases for Vertex(01:03:04) Relay Operations and Spam Control(01:11:01) Current State of the Nostr Ecosystem(01:17:10) Community Building and Onboarding(01:24:08) Closing Thoughts and Future PlansVideo: https://primal.net/e/nevent1qqs8vy4xuuny2hejghpjl57f77hh0t65gthaqhmjdwlwy7rr4ng3pzslchs0g support dispatch: https://citadeldispatch.com/donatenostr live chat: https://citadeldispatch.com/streamodell nostr account: https://primal.net/odelldispatch nostr account: https://primal.net/citadelyoutube: https://www.youtube.com/@CitadelDispatchpodcast: https://serve.podhome.fm/CitadelDispatchstream sats to the show: https://www.fountain.fm/rock the badge: https://citadeldispatch.com/shoplearn more about me: https://odell.xyz

We have a powerful conversation about dedication, innovation, and impact in the cystic fibrosis community in this podcast. I'm joined by two incredible guests from MVW Nutritionals: Mike Walters and Jason Vandiver.Mike Walters is a true pioneer in pharmaceutical business and innovation, with nearly four decades of experience. He began his career at Johnson & Johnson, where he spent 14 years in leadership roles across sales, marketing, and management development. In 1996, Mike launched his first company to help organizations navigate product commercialization in the U.S. Since then, his work in the CF space has been nothing short of groundbreaking. He founded and led Source CF, MVW Nutritionals, and CF Global Services, playing a key role in bringing many standard-of-care treatments to market. A Vanderbilt graduate with degrees in Biochemistry and Chemistry, Mike brings both scientific insight and a deep commitment to rare disease care.Joining him is Jason Vandiver, Chief Operating Officer of MVW Nutritionals. A proud Alabama native, Jason earned his degree in Finance from the University of Alabama at Birmingham and spent 16 years in banking before joining MVW during a time of rapid growth. He now helps lead the multimillion-dollar, family-owned company that's become a global leader in nutritional products for patients with CF and non-CF EPI.In this episode, Mike and Jason share their personal stories, the importance of strong partnerships, and the real challenges patients and families are facing—especially as funding landscapes continue to shift. We explore the power of empathy, the strength of community support, and why transparency in nonprofit operations matters now more than ever.It's a conversation about hope, action, and what's ahead as we work together to support those who need us most.   Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

In this episode RCP Medicine Podcast, we are joined by Dr John Dean, Clinical Vice President at the Royal College of Physicians and a physician in East Lancashire, and Dr John Ford, an academic public health doctor and Senior Clinical Lecturer at Queen Mary University. Together. They explore the multifaceted nature of health inequalities and discuss actionable steps physicians can take to address these disparities. Both share their personal experiences and professional insights into health inequalities and how it shaped their understanding of social and economic disadvantages. They discuss the structural factors within society that lead to health inequalities and emphasise the importance of creating a fairer, more inclusive society. The conversation focusses on the role of clinicians in addressing health care inequalities and the need for continuous improvement in healthcare design and delivery.ResourcesBridging the gap: a guide to making health inequalities a strategic priority for NHS leadersA snapshot of UK doctors: experiences of health inequalitiesSupporting clinicians to address health inequalities in practiceRCP view on health inequalities: a call to action for a cross-government strategyRCP LinksEducation and learning | RCP Events | RCP Membership | RCP Improving care | RCP Policy and campaigns | RCP RCP Social MediaInstagramLinkedInFacebookXBlueskyCreditsMusic by bensound.comFundingThis episode was funded by Vertex Pharmaceuticals (Europe) Limited. Vertex had no involvement in the creation and elaboration of this episode and all views and opinions expressed by the presenter and guests are solely their own.

Substack is where I discovered Dr. MeiLan Han! I was browsing through and was pleasantly surprised to read an article, and learn that she wrote a book called, Breathing Lessons. And to top it off, she's from my home state of Michigan. I also learned the Dr. Han's book was “a passion project during the pandemic.”I'm delighted to share a conversation with Dr. MeiLan Han, one of the country's most respected voices in lung health and a tireless advocate for people living with chronic respiratory conditions.Dr. Han is a Professor of Medicine and Chief of Pulmonary and Critical Care at University of Michigan Health. She's not only cared for patients at the bedside but has devoted her career to understanding lung disease at its roots, with a special focus on chronic obstructive pulmonary disease (COPD), a condition that remains widely under-recognized and underfunded. Through her research, Dr. Han is helping to uncover how diseases like COPD affect the lungs in different ways, with the goal of making treatment more precise, more effective, and more personalized.Her journey began at the University of Washington and continued through specialized training at the University of Michigan, where she also earned a Master's degree in Biostatistics and Clinical Study Design. Today, she leads research funded by the National Institutes of Health (NIH), serves on national advisory boards for the COPD Foundation and the American Lung Association, and contributes to global guidelines that shape how lung disease is diagnosed and treated.Dr. Han also serves as Deputy Editor of the American Journal of Respiratory and Critical Care Medicine, helping to guide the direction of clinical practice and research in pulmonary medicine.If you or someone you love is living with a chronic lung condition, Dr. Han's insight is not only encouraging, it's essential. I'm so grateful to bring her voice to this platform. How many breathes do we take in a lifetime? It's fascinating to discuss and you'll hear the answer in our podcast.Lung health, do you think about it?To get her book: https://www.amazon.com/Breathing-Lessons-Doctors-Guide-Health-ebook/dp/B08X2ZFGNZ/ref=tmm_kin_swatch_0 Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

High NRJ for your summer, much love !Peace Playlist : 1Matt Sassari / BLRThe Incident (extended mix) (5:51) 126 BPMTruesoul; 2BLR / Matt SassariClose Encounters (extended mix) (4:48) 128 BPMTruesoul; 3Carlo Lio / BorisJAQ (5:15) 131 BPMArcane; 4THE DEVIANTTNoir (5:27) 142 BPMSoma; 5DJ DextroBeautiful Day (4:59) 142 BPMMutual Rytm; 6JancenVertex (6:25) 142 BPMDrawner; 7Johannes AstrupSalsa Lessons (5:53) 142 BPMDrawner; 8DJ DextroMero Acaso (5:00) 142 BPMCodein Music; 9Genex / STIPPOut Of Turn (6:20) 144 BPMPlanet Rhythm; 10Confidential Recipe / DJ HausFlange Romance (4:32) 133 BPMDance Trax.   minimal show on iTunes minimal show rss feed   

Join clinical experts Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, Madhuri M. Vasudevan, MD, MPH, FACE, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, to learn how the AACE Patient Journey of Diabetes Technology supports people with diabetes in navigating their treatment options with confidence. This patient-friendly resource, developed from AACE clinical guidelines and reviewed by Diabetes Sisters, a leading patient advocacy organization, provides clear and accurate information on diabetes technologies, from glucose monitors to insulin delivery devices. The experts also highlight how members of the endocrine care team are using this tool to empower people with diabetes to manage their journey. This episode is brought to you with the support of Abbott, Novo Nordisk, Medtronic, and Vertex.

Monopolies! They're a problem as old as our country itself. On this week's TLDR, we talk to Denise Hearn and Vass Bednar, authors of The Big Fix: How Companies Capture Markets and Harm Canadians, about how Canadian companies got so big. And, we look at a surprising proposal for tackling the problem (at least in the airline industry). Plus, we explore how a new wonder drug could spell the end of the opioid epidemic. And, we watch as the pump and dump gets a makeover for the digital age.This episode was hosted by Devin Friedman, business reporter Sarah Rieger and former hedgefunder Matthew Karasz, with appearances by writers Vass Bednar and Denise Hearn. Follow us on other platforms, or subscribe to our weekly newsletter: linkin.bio/tldrThe TLDR Podcast is offered by Wealthsimple Media Inc. and is for informational purposes only. The content in the TLDR Podcast is not investment advice, a recommendation to buy or sell assets or securities, and does not represent the views of Wealthsimple Financial Corp or any of its other subsidiaries or affiliates. Wealthsimple Media Inc. does not endorse any third-party views referenced in this content. More information at wealthsimple.com/tldr.

The Rollup TV is brought to you by:Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Vertex: https://vertexprotocol.com/Subsquid: https://www.sqd.ai/Summer: https://summer.fi/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Introduction04:54 Market Trends and Stablecoins07:18 Avi Patel and Kled Controversy18:39 AI and Token Economics30:02 Macro Economic Insights with Will Clemente52:11 Transitioning to New Guests and Topics54:06 Exploring Investment Trends in Crypto and AI55:59 The Future of Security in Crypto Transactions58:47 Self-Custody vs. Custodial Solutions in Crypto01:02:06 Institutional Interest in Staking and ETFs01:06:41 Research Trends and Contrarian Investments in Crypto01:09:06 Debating Proof of Stake and Governance Models01:12:51 Texas Bitcoin Reserve and Legislative Changes01:14:56 Debate on Central Limit Order Books and Infrastructure01:40:07 Exploring Hyperliquid and User Experience01:45:36 Interoperability and Application-Specific Rollups01:50:40 The Future of Composability in DeFi01:58:49 The Role of Trust in Autonomous Finance02:25:58 Agented Commerce and the Future of AI in Finance

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The FDA's Center for Drug Evaluation and Research (CDER) head, Jacqueline Corrigan-Curay, is leaving the agency in July, becoming the latest in a series of FDA leaders to depart. Eli Lilly is facing concerns about gastrointestinal side effects for their weight loss pill, Orfoglipron, despite brushing off these worries. Vertex's cell therapy for diabetes shows promise, but questions remain about its market potential. HHS Secretary Robert F. Kennedy Jr. has restacked the CDC's vaccine advisory committee, claiming conflicts of interest within the previous group, which experts argue may impact the committee's apolitical nature. Prothena has downsized following a failure in an Al amyloidosis trial, and Novavax is adapting to regulatory uncertainty. Overall, the FDA is experiencing significant turnover in leadership, and challenges persist in drug development and regulation.

In this episode of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, speak with John Buse, MD, PhD, of the University of North Carolina School of Medicine, about the treatment phase of the CATALYST trial. Findings from the phase 4 CATALYST trial suggest that mifepristone (Korlym), a glucocorticoid receptor antagonist, significantly improves glycemic control, reduces body weight, and lowers waist circumference in patients with hypercortisolism and difficult-to-control type 2 diabetes—offering a promising therapeutic option for a population with limited treatment success. The two-part, multicenter study enrolled 1055 adults with type 2 diabetes and HbA1c >7.5% despite optimized therapy. In part 1, participants underwent dexamethasone suppression testing to identify hypercortisolism, defined by post-test cortisol levels >1.8 µg/dL and dexamethasone >140 ng/dL. Results revealed a 24% prevalence of hypercortisolism in this population (95% CI, 21.4–26.7%). Part 2 randomized 136 patients with confirmed hypercortisolism in a 2:1 ratio to receive mifepristone or placebo for 24 weeks. The primary endpoint was change in HbA1c. Mifepristone treatment led to a least squares mean HbA1c reduction of 1.3 percentage points compared to placebo (95% CI, –1.81 to –0.83; P < .001). Secondary endpoints also favored mifepristone: body weight decreased by 5.12 kg (95% CI, –8.20 to –2.03), and waist circumference dropped by 5.1 cm (95% CI, –8.23 to –1.99) relative to placebo. Despite its efficacy, 49% of mifepristone-treated patients discontinued therapy, compared to 18% on placebo. Adverse events included hypokalemia, fatigue, nausea, vomiting, and elevated blood pressure, consistent with the drug's known safety profile. During the episode, which was recorded during the 85th Scientific Sessions of the American Diabetes Association (ADA 2025), Buse provides hosts with a deep dive into the background of the trial, prevalence of hypercortisolism in difficult-to-control type 2 diabetes, and the historic relevance of the CATALYST results. Buse also discusses how the trial offers insight into dosing approaches with mifepristone and advocates for broader cortisol screening in patients with complex type 2 diabetes—suggesting that ADA Standards of Care should reflect these findings. Relevant disclosures for Isaacs include Eli Lilly and Company, Novo Nordisk, Sanofi, Abbott Diabetes Care, Dexcom, Medtronic, and others. Relevant disclosures for Bellini include Abbott Diabetes Care, MannKind, Provention Bio, and others. Relevant disclosures for Buse include Altimmune, AstraZeneca, Boehringer-Ingelheim, CeQur, Corcept Therapeutics, Eli Lilly, embecta, Moderna, Novo Nordisk, Tandem, Vertex, and others.

The Rollup TV is brought to you by:Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Vertex: https://vertexprotocol.com/Subsquid: https://www.sqd.ai/Summer: https://summer.fi/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Introduction and Format Changes06:05 Meme Tweets and Community Engagement09:58 Market Analysis: Stablecoins and Trends11:22 Guest Segment: Trading Insights with Jake27:28 Security Concerns in Crypto29:10 Guest Segment: Insights from Reagan on Market Trends52:29 Exploring Zero-Knowledge Technology and Its Applications56:19 The Rise of Stablecoins in Emerging Markets59:38 The Future of Payment Solutions with Stablecoins01:03:57 Building Native Rollups and Their Impact on Ethereum01:09:51 The Shift Towards Revenue in DeFi Protocols01:23:19 Navigating Challenges in the Crypto Landscape01:34:28 Innovations in Internet Capital Markets with Dupe

The Rollup TV is brought to you by:Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Vertex: https://vertexprotocol.com/Subsquid: https://www.sqd.ai/Summer: https://summer.fi/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Global Tensions and Market Reactions04:40 Coinbase and Military Sponsorship Controversy06:09 Hyperliquid: The New Crypto Sensation?09:30 Eigen Layer and the Future of Decentralized Apps11:54 Kraken's New L2 Token: Ink and Market Dynamics15:19 AI Investments and Market Insights39:23 Market Analysis with TraderMain46:21 Market Sentiment and Altcoin Dynamics49:34 The Role of Movement Coins in Trading52:28 The Meme Coin Phenomenon and Its Implications53:51 Trading Strategies: Gainzy vs. Ansem58:22 The Evolution of Breakout and Prop Trading01:04:33 Diversifying Income in Crypto01:06:31 Comparative Analysis of Fart Coin and Hype Coin01:11:46 Market Positioning Ahead of FOMC01:14:10 Revenue Models in Crypto01:22:05 WorldCoin's Potential and User Distribution01:31:21 CoinFund's Investment Insights and Success Stories

"Oh, the people you'll meet, and the places you'll go..."That classic Dr. Seuss line couldn't have been more true when I found myself at a rare disease conference, taking with Dr. Gabriel Cohn. A quiet presence with a resume that reads like a roadmap through the last 30 years of rare disease breakthroughs, Dr. Cohn is the kind of person who reminds you just how much heart and science it takes to change lives.Dr. Gabe Cohn is the Executive Director and Medical Director of the Rosenau Family Research Foundation. He stepped into the role in October, bringing with him over three decades of experience that spans academic medicine and the biotechnology industry. A licensed, board-certified Clinical Geneticist and Obstetrician-Gynecologist, Dr. Cohn has contributed to the development of multiple therapeutics aimed at treating rare genetic disorders—a career built on both clinical precision and compassionate innovation.Beyond RFRF, he's also the Chief Medical Officer at iECURE, Inc., a biotech company pioneering gene editing therapies for rare diseases. His prior leadership roles at Homology Medicines, AVROBIO, OvaScience, and Shire reflect a steady focus on advancing gene therapy and editing platforms. Since 2017 alone, he's played a pivotal role in getting five different cell and gene therapy programs past the critical regulatory gatekeeping stages of IND and CTA submissions.Dr. Cohn isn't just a scientist—he's a builder, a connector, and a relentless advocate for the potential of genetic medicine to rewrite the future for patients with rare diseases.If you would like to get a hold of the Rosenau Foundation: https://rosenaufoundation.org Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

The Rollup TV is brought to you by:Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Vertex: https://vertexprotocol.com/Subsquid: https://www.sqd.ai/Summer: https://summer.fi/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Introduction to The Roll Up TV and Guests01:13 Recent Market Developments and Token Collapses03:39 Bybit's Hybrid DEX Announcement06:05 ETF Filings and Staking Language09:00 Trump and Tron Going Public11:50 Introduction to Himanshu and Sentient12:35 The Vision Behind Sentient and Decentralized AI18:20 The Importance of Verification in AI24:29 Challenges in AI and Crypto Integration28:20 Innovative Projects within the Sentient Ecosystem33:05 DC Builder and Zero Knowledge Machine Learning40:56 Proof of Personhood and the Future of Identity44:33 Decentralized Identity and ZK Technologies50:02 AI in Crypto: Current Landscape and Innovations54:42 The Future of Identity Platforms and User Privacy01:00:08 Blockchain Bottlenecks: Execution vs. Consensus01:05:45 Institutional Interest Beyond Ethereum01:08:32 The Dynamics of On-Chain Speculation01:12:14 The Role of Wallets in User Retention01:18:52 The Future of Stablecoins and AI Integration01:28:51 The Future of Payments: Stablecoins vs. Real-Time Payment Networks01:35:33 The Role of FinTech in Crypto Payments01:36:30 Understanding the Value of Tokens in Crypto01:49:03 JP Morgan's Entry into Stablecoins01:52:20 Building a Brand: Azuki and the Anime Industry

187 - Mason Marangella (Vertex Effects) In episode 187 of “Have Guitar Will Travel”, presented by Vintage Guitar Magazine, host James Patrick Regan speaks with guitarist and owner and founder of Vertex Effects Mason Marangella. Tom Bukovac calls him “Sweet Mason”. In their conversation Mason tells us about his studio where he has a wealth of classic amplifiers, pedals, pedalboards and a crazy guitar collection with one of just about every type of guitar you would want and Mason tells us about where he gets stuff repaired when it's beyond what he can repair himself. Mason discusses his company Vertex Effects and what he does: buffers, boosts pedalboards all used by the top session guitarists as well as performing guitarists. Mason also talks about his YouTube channel and podcast “Chairmen of the Board” where Mason and his contemporaries discuss pedals, pedalboards and their components. Mason tells us how he initially got his pedals in to the hands of the top Nashville players and how he started in the field of pedals in the first place. Mason explains what a “buffer” does and the optimum pedal signal chain. Mason talks about a project he documented on YouTube having a Gibson R9 Les Paul transformed into a 1959 Gibson Les Paul the way 1956 Goldtop Les Pauls are transformed into the 1958 features and what the results were. Finally Mason takes us through what he's looking at for the future. . To find out more about Mason and Vertex Effects you can go to his website vertexeffects.com or the Vertex YouTube channel. Or check out “Chairmen of the Boards” wherever you listen to podcasts. . Please subscribe, like, comment, share and review this podcast! . #VintageGuitarMagazine #MasonMarangella #VertexEffects #BoutiquePedals #PedalBoards #FuzzBox #theDeadlies #BufferPedal #ChairmenoftheBoards #TomBukovac #haveguitarwilltravelpodcast #HGWT Please like, comment, and share this podcast! Download Link

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The CDC has reinstated around 460 employees who were previously fired, with the rehired staff working on viral disease prevention efforts and sexual health testing labs. This comes amid protests and shake-ups at the agency, including the overhaul of the vaccine advisory committee. Experts are concerned about newly appointed members, some of whom are known anti-vaxxers, potentially relitigating recommendations. Sen. Bill Cassidy is being urged to step up in response to these concerns.In other news, NuVation has received FDA approval for its oral lung cancer drug, Biontech has acquired CureVac in a $1.25 billion all-stock deal, and RFK Jr. has named new CDC vaccine advisors following a "clean sweep." Additionally, InVitro Cell Research is focused on discovering interventions to slow aging and prevent age-related diseases and is hiring scientists. The newsletter also includes information on layoffs at Genentech and Vertex.RFK Jr. has named eight new members to the CDC vaccine committee, replacing the 17 members he removed earlier in the week. The new choices seem to align with Kennedy's anti-vaccine views, causing concern among analysts. The HHS secretary's decision to appoint these scientists has raised questions about the committee's future direction.

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The American Medical Association is calling for a Senate probe into RFK Jr. after he removed all 17 members of the CDC's vaccine advisory board. They are also urging an immediate reversal of the HHS Secretary's decision. In other news, FDA leaders promise support for gene therapy as it faces challenges, Novo Nordisk invests over $800 million in discovering oral obesity drugs, and a new company, InVitro Cell Research, focuses on interventions to slow aging and prevent age-related diseases. FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article outlining the FDA's priorities, including accelerating cures and deploying artificial intelligence quickly. Other news includes Lilly's muscle-preserving treatment pact, Vertex laying off staff after axing a diabetes asset, and Genentech reshuffling in South San Francisco. Recursion cuts workforce by 20%.FDA leaders have pledged support to gene therapy makers as the industry faces challenges in commercialization. Despite huge valuations, gene therapies are struggling to reach the market. Poor communication about the value of groundbreaking treatments is hindering their prospects. Right of first negotiation deals do not always lead to mergers and acquisitions, as found by Jefferies in their analysis of licensing deals. Trilink's new comprehensive IVT kit simplifies the production of mRNAs. In other news, Lilly strikes a $650 million deal for a muscle-preserving treatment, Odyssey ends its quest for Nasdaq, BMS expands its radiopharma presence, and SpliceBio secures $135 million in funding for protein splicing medicines. Novo ups its obesity efforts with an $800 million pact, while Cullinan makes a $700 million deal for autoimmune T cell engager in China.Thank you for listening to Pharma and Biotech Daily.

The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Introduction to the Roll Up TV and Guests02:10 Regulatory Developments in DeFi09:17 Hot Takes on Crypto Networks and Moats13:41 Insights from Dimitri on VC Landscape18:00 Quantum Computing and Its Impact on Bitcoin24:30 The Rise of Decentralized Physical Infrastructure Networks30:14 Future of AI and Decentralized Compute36:08 Discussion with DeFi Dad on Ethereum and DeFi Market43:13 Ethereum's Resilience and User Perspective45:41 Innovations in DeFi and New Financial Primitives53:11 The Future of Airdrops and Marketing Strategies01:05:43 Leadership Transition and the ZK Market01:10:05 The Rise of ZK Technology and Its Implications01:19:34 Privacy in ZK Applications and Future Use Cases01:28:25 Real-Time Proving and Performance Milestones01:30:17 The Role of Zero-Knowledge Proofs in Crypto01:31:46 Understanding Chaos Labs and Oracle Problems01:39:21 Resilience in DeFi Protocols01:42:40 The Rise of Central Limit Order Books01:48:45 Solana ETFs and Institutional Interest in Crypto01:51:05 The Evolution of Crypto Media and DeFi Coverage02:04:12 Ethereum Foundation's Shift Towards DeFi

In this episode, we sit down with Joshua Vanderplate, CEO of Vertex Mechanical, a trusted name in heating, cooling, electrical, and plumbing services for over 40 years. Serving Lancaster, Berks, and Lebanon counties, Vertex Mechanical has built a reputation for quality craftsmanship, community-focused service, and their enduring motto: Here For Your Comfort™. Joshua shares the company's journey, insights on leading in the trades industry, and what it takes to maintain trust and excellence across decades of service. Whether you're a homeowner, aspiring entrepreneur, or simply curious about what goes into running a successful service business, this episode offers valuable takeaways.

The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Introduction to DeFi and Recent Headlines02:12 SEC Talks and Market Structure Bill05:09 Regulatory Clarity and Its Implications06:09 Demand for New Tokens and ICOs08:26 Convergence of Markets and Media11:24 Introduction of Rune and Maker's Evolution19:02 Circle's IPO and Its Impact on the Industry21:25 Sky's Business Model and User Base24:37 Targeting Mercenary Capital in DeFi27:27 Sky Agent Framework and Its Functionality33:30 DeFi Interoperability and Notable Projects35:53 Navigating the Risk Framework for Profit Generation38:09 The Exponential Bet on Star Ecosystems40:01 The Future of Stablecoins and AI in Finance41:49 The Resurgence of DeFi and Institutional Interest45:32 Innovative On-Chain Applications and Yield Opportunities49:23 The Role of Ethereum Foundation in DeFi52:12 Building an Incubator for Ethereum Startups54:33 The State of Interoperability in Blockchain01:01:03 Evaluating the Future of Layer 1s and Applications01:12:56 The Stablecoin Boom and Investment Opportunities01:17:21 IPO Trends in Crypto and On-Chain IPOs01:21:11 The Rise of New Founders in Crypto01:26:08 Vibes and Financialization: The Degenification of Society01:41:32 User Experience in Crypto Apps and Wallets

Damian Sanchez, (Damian J to music fans) is a Miami-based jazz musician. A car accident landed him in the hospital with multiple fractures to his leg. Once there, he faced the difficult decision of whether or not to take the pain medication that was offered to him. With patients like Damian in mind, Dr. Paul Negulescu and the research team at Vertex are thinking differently about pain – they’re investigating potential non-opioid based treatment options that aim to target pain differently. This episode of Targeting the Toughest Diseases is sponsored by Vertex Pharmaceuticals.See omnystudio.com/listener for privacy information.

The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Trump's Crypto Wallet Launch03:08 The Death of the Crypto Foundation Model06:09 Ethereum's New Model and Strategic Goals09:03 The Future of Ethereum and Its Competition11:49 Delphi's AI Month and Investment Strategies18:05 Building on Athena: The Ethereal Project42:10 The Evolving Landscape of On-Chain Trading43:08 Innovative Features and User Engagement45:58 Building a Vertically Integrated DeFi Ecosystem49:23 Liquidity Challenges and Strategies52:20 User Base and Market Positioning56:08 Iterative Product Development and Success01:00:52 Balancing Adoption and Revenue Generation01:06:31 Institutional Relationships and Tokenization01:10:50 Future of Stablecoins and Market Trends01:25:15 The Rise of Hyper Liquid Trading01:27:11 Shifting Perspectives on Crypto Foundations01:28:36 The Future of Tokenomics and Revenue Generation01:34:39 Founders' Evolving Approach to Business Models01:38:06 New Hampshire: A Hidden Crypto Hub?01:40:34 The Importance of Revenue in Crypto Projects01:43:25 Comparing Ethereum and Solana Events01:45:23 The Lore of Lawrence and Wildcat's Unique Marketing01:51:50 Innovations in Under-Collateralized Lending01:56:58 The Future of Liquidation Mechanisms in DeFi

The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-disclTimestamps00:00 Trump's Crypto Wallet Launch03:08 The Death of the Crypto Foundation Model06:09 Ethereum's New Model and Strategic Goals09:03 The Future of Ethereum and Its Competition11:49 Delphi's AI Month and Investment Strategies18:05 Building on Athena: The Ethereal Project42:10 The Evolving Landscape of On-Chain Trading43:08 Innovative Features and User Engagement45:58 Building a Vertically Integrated DeFi Ecosystem49:23 Liquidity Challenges and Strategies52:20 User Base and Market Positioning56:08 Iterative Product Development and Success01:00:52 Balancing Adoption and Revenue Generation01:06:31 Institutional Relationships and Tokenization01:10:50 Future of Stablecoins and Market Trends01:25:15 The Rise of Hyper Liquid Trading01:27:11 Shifting Perspectives on Crypto Foundations01:28:36 The Future of Tokenomics and Revenue Generation01:34:39 Founders' Evolving Approach to Business Models01:38:06 New Hampshire: A Hidden Crypto Hub?01:40:34 The Importance of Revenue in Crypto Projects01:43:25 Comparing Ethereum and Solana Events01:45:23 The Lore of Lawrence and Wildcat's Unique Marketing01:51:50 Innovations in Under-Collateralized Lending01:56:58 The Future of Liquidation Mechanisms in DeFi

From Costco to Connection: Podcast Advice That Changed EverythingWhen I spotted a feature on podcasting in The Costco Connection, I was excited. When I saw Michelle Glogovac featured? I knew I had to reach out. That decision turned into one of the best moves I've made for growing my podcast.Michelle,  THE Podcast Matchmaker®, publicist, and author of How To Get On Podcasts, shared simple, powerful strategies that helped expand my reach. One standout? Getting featured on other podcasts. It boosted my visibility, brought in new listeners, and gave me fresh insights into how other hosts run their shows.In this episode, Michelle shares her approach to storytelling, visibility, and the importance of showing up. Her message: Your story is your superpower.If you want to grow your platform and connect with more listeners, don't miss this one.“Your story is your superpower. The more you share it, the more people you help—and the more you grow in the process.”— Michelle Glogovac,The Podcast Matchmaker®. Michelle is terrific and you will hear and relate to her infectious personality. You'll want to be her best friend!Find out more or connect with Michelle:Author: How To Get On Podcasts Podcast Host:  My Simplified LifeFounder and CEO: The MLG Collective  Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

The Rollup TV : Monday, June 2ndTimestamps00:00 Concentrated Liquidity and Trading Dynamics02:52 Community Building vs. Customer Generation06:08 Navigating Pre and Post TGE Strategies09:01 The Role of Oracles in DeFi11:55 Yield Opportunities in DeFi14:45 Hidden Gems and Overlooked Yields18:01 Balancing Risk and Return in DeFi21:04 Starting in DeFi: Tips for Newcomers36:46 Jacquelyn Intro and the Avalanche Summit39:01 Insights from Vlad at Robinhood41:23 Policymakers and the Future of Crypto44:10 Understanding the Anti-Crypto Sentiment46:31 Founding Token Relations49:11 The Role of Token Relations51:42 Macro Analysis and Its Impact on Crypto54:32 Fiscal Dominance and Bitcoin's Future01:00:46 Global Trade Dynamics and Bitcoin's Position01:05:22 July and August Market Predictions01:12:52 Navigating Fiscal Deficits and Currency Dynamics01:16:14 The Unsustainable Fiscal Path and Hyperinflation Concerns01:18:41 Running the Economy Hot01:22:36 Tariff Policies and Capital Controls01:23:39 The Rise of BRICS and Dollar Diversification01:24:37 Evaluating the Dollar Milkshake Theory01:26:07 Market Predictions and Seasonal Trends01:29:14 Multiplier: A New Player in DeFi01:35:10 User Experience and Conversion Strategies in DeFi01:42:07 Building a Successful Crypto BusinessThe Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-discl

Penthol v. Vertex Energy

Alan Feld is the founder and managing partner of Vintage Investment Partners. Prior to founding Vintage, Alan Feld was a General Partner at Israel Seed Partners and at Vertex Ventures. Prior to Vertex, Alan was the Managing Director of Evergreen Capital Markets/Robertson Stephens Israel. Alan received an MBA from York University in Toronto, an L.L.B. from Osgoode Hall Law School in Toronto and a B.A. in Commerce and Finance from the University of Toronto.

The Rollup TV presents: Mammoth May.The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Frax: https://frax.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-discl

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former Chinook board member, Rouzbeh Haghighat, has been indicted for insider trading related to Novartis' $3.2 billion acquisition of the company. Despite this scandal, pharma R&D spending increased in 2024, climbing 1.5% across the global pharmaceutical sector. The acquisition of SiteOne by Lilly follows Vertex into the non-opioid pain space, providing diversification for Lilly, which has been focusing on obesity and diabetes treatments. Meanwhile, AbbVie's Allergan cuts over 200 staff after a botched marketing campaign, and Inflarx axes a rare skin disease study due to disappointing late-stage data.AGC Biologics will be at Bio International in Boston to showcase their global capabilities in drug production. Vaccine overhaul, rocket grounding, and drug price transparency are also highlighted in the latest news. Biogen's strategy for Zurzuvae shifts as obstetricians/gynecologists rise to the front lines. Drug price transparency in the US is discussed as being easier said than done. Additionally, Rocket's gene therapy for Danon disease is on hold after a patient death, and four biotechs are facing uncertainty in the COVID-19 vaccine landscape.Global pharmaceutical companies are increasing their research and development spending despite political and economic challenges. Biogen is shifting its strategy for the drug Zurzuvae as obstetricians and gynecologists become more involved. Drug price transparency in the US is still a challenge, despite efforts to increase transparency. Trilink has introduced a new poly(A) tail modification to enhance protein expression.In other news, a former Chinook board member has been indicted for insider trading, Trump has appointed Dr. Oz to lead drug pricing negotiations, and Lilly is following Vertex into non-opioid pain treatment with a SiteOne acquisition. Sanofi has purchased Vigil for $470 million to reignite an Alzheimer's target.

The Rollup TV presents: Mammoth May.The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Frax: https://frax.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-discl

Live from Mix and Mingle Education Day: A Powerful Conversation with CaregiversIn this deeply moving live episode recorded at the Mix and Mingle Education Day, we brought together a powerful group of caregivers—grandparents, parents, stepparents, dads, and friends—for a heartfelt discussion about the emotional journey of caring for a loved one with cystic fibrosis.What started as a simple idea to gather voices turned into our most beautiful and emotional podcast yet. There were tears, laughter, and unforgettable stories. We were honored to be joined by a Grief Counselor who helped guide us through the complex feelings that surfaced during our conversation.This episode is a raw, real, and uplifting tribute to the strength, vulnerability, and love that caregivers bring to their roles every single day.Join us for a conversation that honors the heart of caregiving and the power of community.You'll hear from:(00:00:00) Laura Bonnell - Host - (Egypt, Foundation programs, legislation)(00:16:49)  Lois Teicher - CF Grandmother (Laura's Mom) (00:19:05)  Natalie Wicks Lois's partner(00:21:36) Julie Weatherhead - Grief Doula(00:28:45)  Sharon Tischio - CF Mom(00:33:08) Cambria Whitaker - CF Mom in a queer/transgender relationship(00:38:55) Theresa Dagget, MSU Clinic, Respiratory Therapist, CF coordinator(00:49:00 ) Dorothy Stratford,CF Family Caregiver(00:52:15) Jillian Rogers Smith, 33 year old CF Patient and Dad, Bill Rogers (01:01:40) CF Mom to 6 year old daughter Louisa(01:07:28) Wendi Tague (Nurse Coordinator) and Claire Haglund (Social Worker) Present but not on the microphone were Joe Bonnell (Laura's husband), Jeannette Bovensie (Dorothy's Mom) and Dani Nettleton and daughter.Claire Haglund: CHaglund@dmc.orgWendi Tague: wtague@dmc.orgLois Teicher (Laura's Mom): Loisteicher@yahoo.comNatalie Wicks: Piccolo35@gmail.comTheresa Daggett: daggett3@msu.eduCambria Whittaker: cambriawhitta@gmail.comDorothy Straford: dstrat701@gmail.comSharon Tischio: stischio@comcast.netJamie Rudnycky: jamie.rudnycky@gmail.comJulie Weatherhead: weathervanecounseling@gmail.comJillian Smith, Jillian's Jay Walkers: jill@jilliansjaywalkers.org   And Jillian's Dad, Bill Rogers Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

The Rollup TV presents: Mammoth May.The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Frax: https://frax.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-discl

The Rollup TV presents: Mammoth May.The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Frax: https://frax.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-discl

Cystic Fibrosis and obesity?  Until recently this has not been a topic of conversation for the CF community. The reason for obesity in the CF community is better health and longer lives, so the concern is now a reality.  University of Michigan CF doctor, Carey Lumeng is researching the issue.  As he says in this podcast, researchers have a lot to learn about the connection between better health in CF and obesity.  We also talk about The Bonnell Foundation fellowship program. A few years ago we started the program to encourage doctors to work in the specialty field of cystic fibrosis. Dr. Lumeng is one of the doctors who oversees this program.Dr. Lumeng is the Frederick G.L. Huetwell Professor for the Cure and Prevention of Birth Defects and Professor in Pediatrics and Molecular and Integrative Physiology. Dr. Lumeng is the Division Chief of Pediatric Pulmonology at the C.S. Mott Children's Hospital and Associate Director of the Michigan MSTP Program.He grew up in Indiana and graduated from Princeton University in Molecular Biology. He received his PhD in Human Genetics and MD from the University of Michigan and completed residency training in Pediatrics in the Boston Combined Pediatrics Residency Program at Boston Children's Hospital and Boston Medical Center. He then completed fellowship training in Pediatric Pulmonology at the University of Michigan and started as faculty in 2006.  He runs a research lab focused on the health effects of obesity and the links between metabolism and lung health. The laboratory participates in both basic science and translational research projects in adult and pediatric obesity. He is funded by the NIH and the CF Foundation for new projects studying the changing causes of diabetes in people with CF.To contact the CF pediatric department (the Bonnell girls are pictured on this page): https://www.mottchildren.org/conditions-treatments/cystic-fibrosis-pediatric?pk_vid=6ff46bd2d38fe04c1739891353f5b28b Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Welcome to The Rollup TV.The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Frax: https://frax.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-discl

Welcome to The Rollup TV.The Rollup TV is brought to you by:Celestia: https://celestia.org/Boundless: https://beboundless.xyz/AltLayer: https://www.altlayer.io/Mantle: https://www.mantle.xyz/Omni Network: https://omni.network/Vertex: https://vertexprotocol.com/Frax: https://frax.com/Join The Rollup Family:Website: https://therollup.co/Spotify: https://open.spotify.com/show/1P6ZeYd..Podcast: https://therollup.co/category/podcastFollow us on X: https://www.x.com/therollupcoFollow Rob on X: https://www.x.com/robbie_rollupFollow Andy on X: https://www.x.com/ayyyeandyJoin our TG group: https://t.me/+8ARkR_YZixE5YjBhThe Rollup Disclosures: https://therollup.co/the-rollup-discl

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The White House has announced a new drug pricing policy that includes the revival of the most favored nations rule and extends to the private markets, leveraging the patent system, drug importation, and more. Meanwhile, Lilly's Zepbound has been found to have a superior benefit-risk ratio compared to Novo's Wegovy, BMS and Sanofi settle a Plavix lawsuit with Hawaii for $700 million, and biopharma companies are focusing on developing a cure for HIV as federal funding for related research is being cut. Sino Biological offers comprehensive solutions for autoimmune diseases, and Roche promises a $300 million investment in China production after a multibillion-dollar investment in the US. On the other hand, Lexeo and IGM have both announced significant layoffs. Novartis CEO has expressed concerns about Trump's pricing controls.Funding for HIV-related research and infrastructure is being cut by the Trump administration, leading biopharma companies like Gilead and Immunocore to focus on finding a cure for HIV. In the field of neurology, there is a need for more precise diagnostic tools to effectively treat neurodegenerative conditions. The new HHS vaccine requirement has been criticized by leading vaccine physician Paul Offit as potentially being anti-vaccine activism disguised as policy. Companies like Novartis, Bayer, and AstraZeneca are exploring new indications and innovations in radiopharmaceuticals, hoping to capitalize on a market that could reach $16 billion by 2033. The FDA has faced delays in reviewing certain drugs, while biotech stocks have fallen after the appointment of Vinay Prasad to succeed Marks at CBER. Vertex has decided to abandon AAV in the gene therapy space.Upcoming events include a webinar on surviving and thriving in the biotech downturn. Job opportunities in the biopharma industry include positions at Takeda, Daiichi Sankyo, and AbbVie. Heather McKenzie, senior editor at BioSpace, is open to suggestions for future coverage topics in neuroscience, oncology, cell & gene therapy, metabolic, or other areas.

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

A 70-year-old person with cystic fibrosis. It's a phrase that wasn't just uncommon a few decades ago—it was virtually unheard of.When Luanne McKinnon was diagnosed in 1969 at just 13 years old, doctors told her parents she might live to be 19 years old. Today, Luanne stands on the edge of her 70th birthday—a milestone that not only redefines possibility but embodies resilience, creativity, and purpose.Born in Dallas, Texas in 1955, Luanne was diagnosed at a time when cystic fibrosis was still barely understood. No vests. No targeted medications. No community. And yet, she carved out a life of profound impact. “I stand as a witness to the possible.” says Luanne McKinnonAfter earning a Master of Fine Art in Painting and a PhD in Art History, she launched a celebrated career in the visual arts—owning an art dealership in New York City, directing major university museums, publishing works, and curating over 35 exhibitions. She even became a Fellow at the prestigious Getty Research Institute.And while that would be more than enough for most of us, Luanne continued to pour herself into advocacy—serving as Co-chair for Stanford's Patient and Family Advisory Committee, raising awareness for CF patients before and after transplant. In 2011, she underwent a successful double-lung transplant at Stanford, and fourteen years later, she is still very much living proof.This episode is not about her equally remarkable husband—EMMY award-winning filmmaker Daniel Reeve—though we'll mention him later. This is about Luanne—her life, her art, her truth, and her refusal to let a diagnosis define the limits of her possibility. She says, “I stand as a witness to the possible.”And after listening to this conversation, I think you'll believe in the possible, too.Welcome, to a very special episode of the Living with cystic fibrosis podcast and our incredible guest, Luanne McKinnon. Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today is Tuesday, May 13th, 2025 Movement of Planets: Sun is at 23 degrees Taurus in the 12th house. Taurus' ruler Venus is in Aries in the 11th house. Aries' ruler Mars is in Leo in 4th house. Moon is at 2 degrees Sagittarius in the 7th house of love and relationships. Mercury is at 5 degrees Taurus in the 12th house. It opposes Black Moon Lilith in Scorpio in the 6th house. It also opposes the Vertex in Libra in the 6th house. Venus is at 8 degrees Aries in the 11th house of friendships and goals sextiles the MC in Aquarius. Mars is at 11 degrees Leo in the 4th house and Sesquiquadrate Saturn at 29 degrees in Pisces. Jupiter is at 23 degrees Gemini in the first house and trines the Vertex in Libra in the 6th house. Saturn is at the critical degree of 29 degrees in Pisces in the 11th house and sextiles the Taurus Ascendant. Uranus is at 27 degrees Taurus in the 12th house and conjuncts Hygiea at 27 degrees Taurus in the 12th House. Neptune is at 1 degree Aries in the 11th house and conjuncts the North Node in Pisces in the 11th house of friendships and goals. Pluto is at 3 degrees Aquarius retrograde and opposes Vulcanus Leo in the 3rd House. Chiron is at 24 degrees Aries in the 12th house of secrets and conjuncts Eris in Aries in the 12th house. Vesta is at 9 degrees Scorpio retrograde in the 6th house. Pallas is at 23 degrees Aquarius in the 10th house. Juno is at 24 degrees Scorpio retrograde in the 6th house. Ceres is at 28 degrees Pisces. The North Node is at 24 degrees Pisces Retrograde in the 11th house. The South Node is at 24 degrees Virgo Retrograde in the 5th house. Learn more about your ad choices. Visit megaphone.fm/adchoices

Join us on the latest episode, hosted by Jared S. Taylor!Our Guest: Peter Donnelly, CEO & Co-Founder at Genomics.What you'll get out of this episode:Genomics' Mission: Founded in 2014, Genomics is bridging cutting-edge genetic research with real-world healthcare solutions.Actionable Insights: Advances now allow actionable health insights for ~70% of people via genetic testing.Strategic Partnerships: Collaborations with companies like Vertex and GSK use genetics to improve drug targeting and trial outcomes.Insurance Innovation: Life insurers are early adopters of genetics to promote longevity and healthier lives.The Future Is Now: With global health systems under pressure, predictive genomics is primed to shift care from treatment to prevention.To learn more about Genomics:Website: http://www.genomics.com/ LinkedIn: https://www.linkedin.com/company/genomics-ltd/Our sponsors for this episode are:Sage Growth Partners https://www.sage-growth.com/Quantum Health https://www.quantum-health.com/Show and Host's Socials:Slice of HealthcareLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/Jared S TaylorLinkedIn: https://www.linkedin.com/in/jaredstaylor/WHAT IS SLICE OF HEALTHCARE?The go-to site for digital health executive/provider interviews, technology updates, and industry news. Listed to in 65+ countries.